Citation Impact
Citing Papers
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
Hepatitis C Virus Attachment Mediated by Apolipoprotein E Binding to Cell Surface Heparan Sulfate
2012
Hepatitis C Virus (HCV) Envelope Glycoproteins E1 and E2 Contain Reduced Cysteine Residues Essential for Virus Entry
2011
Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A #
2009
Cell Culture Systems for Hepatitis C Virus
2013
Hepatitis C virus entry into host cells
2007
Intracellular Proton Conductance of the Hepatitis C Virus p7 Protein and Its Contribution to Infectious Virus Production
2010
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
IFITm1 Is a Tight Junction Protein That Inhibits Hepatitis C Virus Entry
2012
Evaluation of ITX 5061, a Scavenger Receptor B1 Antagonist: Resistance Selection and Activity in Combination With Other Hepatitis C Virus Antivirals
2012
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
Animal Models for the Study of Hepatitis C Virus Infection and Related Liver Disease
2012
Direct-acting and host-targeting HCV inhibitors: current and future directions
2012
Turning Hepatitis C into a Real Virus
2010 StandoutNobel
Role of lipid metabolism in hepatitis C virus assembly and entry
2009
Dicer-TRBP Complex Formation Ensures Accurate Mammalian MicroRNA Biogenesis
2014 StandoutNobel
Regulation of hepatic innate immunity by hepatitis C virus
2013
Hepatitis C viral protein translation: mechanisms and implications in developing antivirals
2011
Host neutralizing responses and pathogenesis of hepatitis C virus infection†
2008
Hepatitis C Virus Infection in Phenotypically Distinct Huh7 Cell Lines
2009
Modification of hepatitis C virus 1b RNA polymerase to make a highly active JFH1-type polymerase by mutation of the thumb domain
2009
Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death
2008
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
2012
Hepatitis C virus expressing flag-tagged envelope protein 2 has unaltered infectivity and density, is specifically neutralized by flag antibodies and can be purified by affinity chromatography
2010
Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
2012 StandoutNobel
The past, present and future of neutralizing antibodies for hepatitis C virus
2014
Cell culture–produced hepatitis C virus impairs plasmacytoid dendritic cell function
2007
Advances in experimental systems to study hepatitis C virus in vitro and in vivo
2015
Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation
2008
Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral
2011
Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes
2009
Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies
2007
TNF-α Induced by Hepatitis C Virus via TLR7 and TLR8 in Hepatocytes Supports Interferon Signaling via an Autocrine Mechanism
2015
Tinkering with Translation: Protein Synthesis in Virus-Infected Cells
2012
Chapter 2 Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems
2008
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
2008 StandoutNobel
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication
2011
Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome
2010
The core of hepatitis C virus pathogenesis
2016
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro
2010
Arylacetamide deacetylase: A novel host factor with important roles in the lipolysis of cellular triacylglycerol stores, VLDL assembly and HCV production
2013 StandoutNobel
Regulation of hepatitis C virus secretion by the Hrs-dependent exosomal pathway
2011
Interferon-stimulated genes and their role in controlling hepatitis C virus
2013
The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity
2010
Failure of innate and adaptive immune responses in controlling hepatitis C virus infection
2011
Hepatitis C Virus Entry
2007 StandoutNobel
Highly Efficient Infectious Cell Culture of Three Hepatitis C Virus Genotype 2B Strains and Sensitivity to Lead Protease, Nonstructural Protein 5A, and Polymerase Inhibitors
2013
Challenges and Promise of a Hepatitis C Virus Vaccine
2019
How do persistent infections with hepatitis C virus cause liver cancer?
2015
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?
2015
A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles
2009
Activity-based Protein Profiling Identifies a Host Enzyme, Carboxylesterase 1, Which Is Differentially Active during Hepatitis C Virus Replication
2010
Innate immune responses in hepatitis C virus infection
2012
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice
2018
HCV and the hepatic lipid pathway as a potential treatment target
2011
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Replication of hepatitis C virus
2007 StandoutNobel
HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice
2015
Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication
2016
Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host
2012 StandoutNobel
Characterization of Novel Splice Variants of Zinc Finger Antiviral Protein (ZAP)
2019 StandoutNobel
Efficient Infectious Cell Culture Systems of the Hepatitis C Virus (HCV) Prototype Strains HCV-1 and H77
2014
Novel Function of CD81 in Controlling Hepatitis C Virus Replication
2010
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
Completion of the Entire Hepatitis C Virus Life Cycle in Vero Cells Derived from Monkey Kidney
2016
Genetic Analysis of the Carboxy-Terminal Region of the Hepatitis C Virus Core Protein
2009 StandoutNobel
An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry
2016
Will There Be a Vaccine to Prevent HCV Infection?
2014
ISG56 and IFITM1 Proteins Inhibit Hepatitis C Virus Replication
2011
Hepatitis C Virus Entry
2013
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains
2012
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors
2009
Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization
2008
Development of an Intergenotypic Hepatitis C Virus (HCV) Cell Culture Method To Assess Antiviral Susceptibilities and Resistance Development of HCV NS3 Protease Genes from HCV Genotypes 1 to 6
2010
Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers
2013 StandoutNobel
Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus
2017 StandoutNobel
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Incorporation of Hepatitis C Virus E1 and E2 Glycoproteins: The Keystones on a Peculiar Virion
2014
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman Primates
2017
Pharmacokinetics and Safety in Cynomolgus Monkeys of a Monoclonal Antibody Targeting Human Scavenger Receptor Class B Type-1 for Hepatitis C Treatment
2013
On the History of Hepatitis C Virus Cell Culture Systems
2013
Structural and Functional Analysis of Hepatitis C Virus Strain JFH1 Polymerase
2009
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells
2019 StandoutNobel
Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system
2012
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Novel Chimeric Genotype 1b/2a Hepatitis C Virus Suitable for High-Throughput Screening
2007
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Hepatitis C Virus Induces CD81 and Claudin-1 Endocytosis
2012
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Virus‐neutralizing antibodies to hepatitis C virus
2013
Hepatitis C Virus: Evading the Intracellular Innate Immunity
2020
Cellular and molecular biology of HCV infection and hepatitis
2009
Viral Quasispecies Evolution
2012
Apolipoprotein C1 Association with Hepatitis C Virus
2008
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Genetic and Functional Characterization of the N-Terminal Region of the Hepatitis C Virus NS2 Protein
2013 StandoutNobel
Immune control and failure in HCV infection—tipping the balance
2014
The Hepatitis C Virus NS4B Protein Can trans -Complement Viral RNA Replication and Modulates Production of Infectious Virus
2008
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies
2008
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
The Multiple Functions of TRBP, at the Hub of Cell Responses to Viruses, Stress, and Cancer
2012
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Emerging concepts in immunity to hepatitis C virus infection
2013
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
Effect of Cell Polarization on Hepatitis C Virus Entry
2007
Genetic Dissection of the Host Tropism of Human-Tropic Pathogens
2015
Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus
2011
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Targeting HCV Entry For Development of Therapeutics
2010
Works of Daisuke Akazawa being referenced
An infectious and selectable full‐length replicon system with hepatitis C virus JFH‐1 strain
2007
Cell culture and infection system for hepatitis C virus
2006
Hepatitis C Virus Controls Interferon Production through PKR Activation
2010
Trans-complemented hepatitis C virus particles as a versatile tool for study of virus assembly and infection
2012
Production and characterization of HCV particles from serum-free culture
2011
Characterization of infectious hepatitis C virus from liver-derived cell lines
2008
Biological properties of purified recombinant HCV particles with an epitope-tagged envelope
2010
The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles
2007
RNA Polymerase Activity and Specific RNA Structure Are Required for Efficient HCV Replication in Cultured Cells
2010
In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosis
2011
Neutralizing Antibodies Induced by Cell Culture–Derived Hepatitis C Virus Protect Against Infection in Mice
2013
Hepatitis C Virus Reveals a Novel Early Control in Acute Immune Response
2011
The NS3 Helicase and NS5B-to-3′X Regions Are Important for Efficient Hepatitis C Virus Strain JFH-1 Replication in Huh7 Cells
2007
Production of Infectious Chimeric Hepatitis C Virus Genotype 2b Harboring Minimal Regions of JFH-1
2011
CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection
2007
Novel Cell Culture-Adapted Genotype 2a Hepatitis C Virus Infectious Clone
2012